| Literature DB >> 35054614 |
Betty Revon Liu1, Shiow-Her Chiou2, Yue-Wern Huang3, Han-Jung Lee4.
Abstract
Recently, membrane-active peptides or proteins that include antimicrobial peptides (AMPs), cytolytic proteins, and cell-penetrating peptides (CPPs) have attracted attention due to their potential applications in the biomedical field. Among them, CPPs have been regarded as a potent drug/molecules delivery system. Various cargoes, such as DNAs, RNAs, bioactive proteins/peptides, nanoparticles and drugs, can be carried by CPPs and delivered into cells in either covalent or noncovalent manners. Here, we focused on four arginine-rich CPPs and reviewed the mechanisms that these CPPs used for intracellular uptake across cellular plasma membranes. The varying transduction efficiencies of them alone or with cargoes were discussed, and the membrane permeability was also expounded for CPP/cargoes delivery in various species. Direct membrane translocation (penetration) and endocytosis are two principal mechanisms for arginine-rich CPPs mediated cargo delivery. Furthermore, the amino acid sequence is the primary key factor that determines the cellular internalization mechanism. Importantly, the non-cytotoxic nature and the wide applicability make CPPs a trending tool for cellular delivery.Entities:
Keywords: cell-penetrating peptides; direct membrane translocation; endocytosis; protein transduction
Year: 2022 PMID: 35054614 PMCID: PMC8778423 DOI: 10.3390/membranes12010088
Source DB: PubMed Journal: Membranes (Basel) ISSN: 2077-0375
Primary Sequences of cell-penetrating peptides.
| CPP | Primary Sequence |
|---|---|
| F4R8 | FFFFGRRRRRRRRGC |
| HR9 | CHHHHHRRRRRRRRRHHHHHC |
| IR9 | GLFEAIEGFIENGWEGMIDGWYGRRRRRRRRR |
| L5a | RRWQW |
| NP1 | stearyl-HHHHHHHHHHHHHHHHRRRRRRRR-NH2 |
| Pas2r12 | FFLIGFFLIGRRRRRRRRRRRR |
| PR9 | FFLIPKGRRRRRRRRR |
| SR9 | RRRRRRRRR |
Figure 1Different cellular entry routes for either cell-penetrating peptides (CPPs) alone or CPP/cargo complexes. Direct membrane translocation and endocytosis are two major routes which have been proposed. Endocytic pathways are further divided into four categories: macropinocytosis, clathrin-mediated endocytosis, caveolae-mediated endocytosis, and clathrin- and caveolae-independent endocytosis.
Primary sequences of four arginine-rich CPPs and their cellular internalization mechanisms.
| CPPs | Peptide Sequences | Cargoes | Entrance Targets | Mechanisms | References |
|---|---|---|---|---|---|
| SR9 | RRRRRRRRR | — | artificial large unilamellar vesicles (LUVs) in 100 nm diameter | lipid raft | [ |
| plasmid DNAs | plant tissues | macropinocytosis | [ | ||
| A549 cells, Sf9 cells, paramecia | unknown | [ | |||
| proteins | A549 cells, plant epidermal cells, mouse skin cells | macropinocytosis | [ | ||
| nanoparticles | A549 cells | multiple pathways | [ | ||
| prokaryotes | macropinocytosis | [ | |||
| HR9 | CHHHHHRRRRRRRRRHHHHHC | — | A549 cells, rotifers, paramecia | unknown | [ |
| plasmid DNAs | A549 cells | direct membrane translocation | [ | ||
| HEK293T cells, Sf9 cells, rotifers, paramecia, mice | unknown | [ | |||
| proteins | rotifers | unknown | [ | ||
| nanoparticles | A549 cells | direct membrane translocation | [ | ||
| rotifers | unknown | [ | |||
| PR9 | FFLIPKGRRRRRRRRR | plasmid DNAs | A549 cells, Sf9 cells, paramecia | unknown | [ |
| nanoparticles | A549 cells | classical endocytosis | [ | ||
| IR9 | GLFEAIEGFIENGWEGMIDGWYGRRRRRRRRR | — | A549 cells | macropinocytosis | [ |
| rotifers | unknown | [ | |||
| plasmid DNAs | A549 cells | classical endocytosis | [ | ||
| rotifers | unknown | [ | |||
| proteins | rotifers | unknown | [ | ||
| nanoparticles | A549 cells | classical endocytosis | [ | ||
| rotifers | unknown | [ |
The properties of four arginine-rich CPPs and their additional modified domains.
| CPP | Additional Modified Domain | Net Charge at pH 7.0 1 | Hydrophilicity 1 | Hydrophobicity 2 | pI 2 | ||||
|---|---|---|---|---|---|---|---|---|---|
| Full Sequence | Domain | Full Sequence | Domain | Full Sequence | Domain | Full Sequence | Domain | ||
| SR9 | — | +9.0 | — | 3.0 | — | 0.77 | — | 13.4 | — |
| HR9 | polyhistidine | +9.82 | +0.82 | 0.95 | −0.58 | −25.32 | −6.34 | 12.8 | 7.5 |
| PR9 | reverted cathepsin D | +9.95 | +1.0 | 1.2 | −0.8 | 19.74 | 31.52 | 13.0 | 10.1 |
| IR9 | INF7 domain | +4.0 | −5.0 | 0.6 | −0.34 | 52.25 | 65.73 | 11.9 | 2.8 |
1 Bachem Peptide Calculator. 2 Thermo Fisher Scientific Peptide Analyzing Tool.